HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Controlled and Selective Photo-oxidation of Amyloid-β Fibrils by Oligomeric p-Phenylene Ethynylenes.

Abstract
Photodynamic therapy (PDT) has been explored as a therapeutic strategy to clear toxic amyloid aggregates involved in neurodegenerative disorders such as Alzheimer's disease. A major limitation of PDT is off-target oxidation, which can be lethal for the surrounding cells. We have shown that a novel class of oligo-p-phenylene ethynylenes (OPEs) exhibit selective binding and fluorescence turn-on in the presence of prefibrillar and fibrillar aggregates of disease-relevant proteins such as amyloid-β (Aβ) and α-synuclein. Concomitant with fluorescence turn-on, OPE also photosensitizes singlet oxygen under illumination through the generation of a triplet state, pointing to the potential application of OPEs as photosensitizers in PDT. Herein, we investigated the photosensitizing activity of an anionic OPE for the photo-oxidation of Aβ fibrils and compared its efficacy to the well-known but nonselective photosensitizer methylene blue (MB). Our results show that, while MB photo-oxidized both monomeric and fibrillar conformers of Aβ40, OPE oxidized only Aβ40 fibrils, targeting two histidine residues on the fibril surface and a methionine residue located in the fibril core. Oxidized fibrils were shorter and more dispersed but retained the characteristic β-sheet rich fibrillar structure and the ability to seed further fibril growth. Importantly, the oxidized fibrils displayed low toxicity. We have thus discovered a class of novel theranostics for the simultaneous detection and oxidization of amyloid aggregates. Importantly, the selectivity of OPE's photosensitizing activity overcomes the limitation of off-target oxidation of traditional photosensitizers and represents an advancement of PDT as a viable strategy to treat neurodegenerative disorders.
AuthorsAdeline M Fanni, Daniel Okoye, Florencia A Monge, Julia Hammond, Fahimeh Maghsoodi, Tye D Martin, Gabriella Brinkley, M Lisa Phipps, Deborah G Evans, Jennifer S Martinez, David G Whitten, Eva Y Chi
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 14 Issue 13 Pg. 14871-14886 (Apr 06 2022) ISSN: 1944-8252 [Electronic] United States
PMID35344326 (Publication Type: Journal Article)
Chemical References
  • Amyloid
  • Amyloid beta-Peptides
  • Amyloidogenic Proteins
  • Peptide Fragments
Topics
  • Alzheimer Disease (metabolism)
  • Amyloid (chemistry)
  • Amyloid beta-Peptides (metabolism)
  • Amyloidogenic Proteins
  • Humans
  • Peptide Fragments (chemistry)
  • Protein Conformation, beta-Strand

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: